Navigation Links
Funding boost in fight against leukaemia
Date:7/3/2008

University of Manchester researchers have been awarded 1.6 million to study a group of genes identified as playing a key role in leukaemia.

The grant, by Leukaemia Research, will fund work analysing a wide range of cancer-causing genes in the hope of targeting their common mechanisms of action for patient benefit.

"All cancers and leukaemias occur because of mutations in certain genes that stop them functioning properly," said Tony Whetton, Professor of Cancer Cell Biology and research leader.

"Mutations in a group of genes leads to unregulated activity in a group of proteins called tyrosine kinases, which change the actions of other proteins, leading to leukaemia."

The team are using state-of-the-art equipment to discover whether the different leukaemia-associated kinases contribute to the disease in the same way; if they do, it offers the opportunity to develop common therapies to block their actions.

"This would potentially be effective for many different types of leukaemia because the mutated kinase genes we are studying occur in several types of blood and bone marrow cancers," said Professor Whetton, who is Head of the School of Cancer and Imaging Sciences.

"What is also exciting is that there are already drugs that are able to block the actions of kinases. These kinase inhibitor drugs are attracting worldwide attention as a new form of treatment for certain cancers including some leukaemias. We hope to add further leukaemias to this list by understanding more fully what this range of kinases do."

Leukaemia Research currently provides more than 3.6 million in funding to the School of Cancer and Imaging Sciences, complementing ongoing research in other areas of the Manchester Cancer Research Centre (MCRC) alliance between the University and the Christie Trust.

This alliance has had a synergistic effect on cancer research in Manchester by promoting cross-disciplinary collaborations and attracting new funding from government, industry and charities.

Professor Whetton said: "In the past few years we have developed a multidisciplinary research approach, employing the latest cutting-edge technologies to take basic research towards clinical relevance as swiftly as possible.

"In so doing, we have built a research platform that not only enables leukaemia research but cancer research in general on the Christie Hospital NHS Foundation Trust site."


'/>"/>

Contact: Aeron Haworth
aeron.haworth@manchester.ac.uk
44-161-275-8383
University of Manchester
Source:Eurekalert

Related medicine news :

1. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. Launch of second European Cancer Research Funding survey
4. SNM applauds NAS study showing need to restore federal nuclear medicine research funding
5. Center gets national funding for child trauma research
6. Southern Research Institutes Neurodegenerative Disease Drug Discovery Program Receives National Institute of Mental Health Funding
7. Biomoda President Testifies Before New Mexico Legislature Supporting Clinical Funding for Early Lung Cancer
8. CPF Urges Congress to Increase Funding for IPF Research in 2009 Federal Budget
9. Wild American Shrimp Board Agrees To Implement New Self-Funding Measures
10. Women Entrepreneurs Urge Veto Override of SCHIP Funding in the House
11. Coalition Urges Congress to Increase Funding for National Health Service Corps
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... February 27, 2017 , ... POUGHKEEPSIE, N. Y. – Peer-reviewed guidelines from the ... studies, the Center for Disease Control ( CDC ) and Infectious Diseases Society of ... Liegner, M.D. has compiled into a single volume a compelling argument that the disease ...
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon Valley Hair Institute, ... announce an upgrade to the company's Yelp listing. Bay Area residents struggling from ... diverse as Platelet Rich Plasma (PRP) therapy, hair transplantation techniques such as Follicular ...
(Date:2/26/2017)... Dublin, Ireland (PRWEB) , ... February 26, 2017 ... ... accreditation, as in 2011 the lab became the world’s first to be ISO/IEC ... d 1 (cat allergen) analysis. , ISO/IEC 17025:2005 is the globally recognised standard ...
(Date:2/26/2017)... KS (PRWEB) , ... February ... ... StaffBridge sets a new technology standard in staffing, scheduling, and reporting for ... monitor, and predict activity throughout the entire staffing process. StaffBridge technology improves ...
(Date:2/25/2017)... , ... February 25, 2017 , ... FCPX users now ... tools from Pixel Film Studios. With ProSharpen Color users have total control over sharpening ... refine their color range. With color spectrum tools users can visually see the color ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 2017 LG Innotek hat heute die weltweit ... beträgt das 1,5-fache des 45-mW-Moduls der Konkurrenz. ... 200 und 280 nm und eignet sich damit für Sterilisationsaufgaben. ... DNA zerstört. Das Produkt von LG Innotek erzeugt UV-Strahlung ... ...
(Date:2/23/2017)... Feb. 23, 2017 ITL Limited, ( ASX: ITD ), ... for the half year ended 31 December 2016 compared with the ... presentation can be viewed here . Highlights ... $1.04m; up 104%) Earnings per share of 2.2 ... of $17.5m (Dec 2015: $15.7m; up 11%) Profit ...
(Date:2/23/2017)... DUBLIN , Feb 23, 2017 Research and ... and Strategies - 2016" report to their offering. ... The latest research Menopause Drugs Price Analysis ... global Menopause market. The research answers the following questions: ... their clinical attributes? How are they positioned in the Global Menopause market? ...
Breaking Medicine Technology: